- Home
- BRY vs MYO Comparison
BRY vs MYO Comparison
Compare BRY & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- MYO
- Stock Information
- Founded
- BRY 1909
- MYO 2004
- Country
- BRY United States
- MYO United States
- Employees
- BRY N/A
- MYO N/A
- Industry
- BRY Oil & Gas Production
- MYO Industrial Specialties
- Sector
- BRY Energy
- MYO Health Care
- Exchange
- BRY Nasdaq
- MYO Nasdaq
- Market Cap
- BRY 186.1M
- MYO 153.0M
- IPO Year
- BRY N/A
- MYO 2017
- Fundamental
- Price
- BRY $2.92
- MYO $2.14
- Analyst Decision
- BRY Buy
- MYO Strong Buy
- Analyst Count
- BRY 2
- MYO 4
- Target Price
- BRY $5.00
- MYO $9.13
- AVG Volume (30 Days)
- BRY 1.4M
- MYO 773.6K
- Earning Date
- BRY 08-08-2025
- MYO 08-05-2025
- Dividend Yield
- BRY 4.14%
- MYO N/A
- EPS Growth
- BRY N/A
- MYO N/A
- EPS
- BRY N/A
- MYO N/A
- Revenue
- BRY $753,737,000.00
- MYO $38,628,624.00
- Revenue This Year
- BRY N/A
- MYO $55.29
- Revenue Next Year
- BRY $0.96
- MYO $27.18
- P/E Ratio
- BRY N/A
- MYO N/A
- Revenue Growth
- BRY N/A
- MYO 97.60
- 52 Week Low
- BRY $2.11
- MYO $2.02
- 52 Week High
- BRY $7.02
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- BRY 52.31
- MYO 21.30
- Support Level
- BRY $2.70
- MYO $2.02
- Resistance Level
- BRY $2.90
- MYO $2.89
- Average True Range (ATR)
- BRY 0.17
- MYO 0.15
- MACD
- BRY -0.02
- MYO -0.00
- Stochastic Oscillator
- BRY 31.16
- MYO 13.79
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).